Meet Alan Valentine, M.D.
Alan D. Valentine, M.D., FAPOS
Department of Psychiatry, Division of Internal Medicine
About Dr. Alan D. Valentine
Alan
Valentine, MD, is a Professor and Chair of the Department of Psychiatry at the
University of Texas MD Anderson Cancer Center. He has over 33 years of
experience in the psychiatric care of patients with cancer. Dr. Valentine’s
clinical interests include the management of cancer-related mood disorders,
delirium, and the effects of central nervous system malignancies. His research
interests include the characterization and treatment of neuropsychiatric side
effects of cancer therapies, especially altered mental status and mood
disorders. Dr. Valentine is a member of the Psychosocial Guidelines Panel for
the National Comprehensive Cancer Network (NCCN); a Fellow and former
President of the American Psychosocial Oncology Society. Dr. Valentine is
board-certified in Psychiatry, Geriatric Psychiatry, and Psychosomatic Medicine.
Read More
Present Title & Affiliation
Primary Appointment
Professor (Joint appointment), Critical Care, Section of Integrated Ethics, The University of Texas MD Anderson Cancer Center, Houston, TX
Clinical Professor, Psychiatry and Behavioral Science, The University of Texas Medical School, Houston, TX
Professor, Psychiatry, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Critical Care, Section of Integrated Ethics, The University of Texas MD Anderson Cancer Center, Houston, TX
Clinical Professor, Psychiatry and Behavioral Science, The University of Texas Medical School, Houston, TX
Professor, Department of Psychiatry, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1986 | The University of Texas McGovern Medical School, Houston, Texas, US, Medicine, MD |
| 1981 | The University of Texas-Arlington, Arlington, Texas, US, Microbiology, BS |
Postgraduate Training
| 1986-1990 | Clinical Residency, Psychiatry, The University of Texas Medical System, Houston, Texas |
Licenses & Certifications
| 2023 | Washington - Medical License |
| 2022 | Georgia - Medical License |
| 2022 | Tennessee - Medical License |
| 2022 | Louisiana - Medical License |
| 2022 | Alabama - Medical License |
| 2022 | Oklahoma - Medical License |
| 2022 | Arizona - Medical License |
| 2022 | Mississippi - Medical License |
| 2021 | Florida - Medical License |
| 2012 | American Board of Psychiatry and Neurology, Subspeciality in Hospice and Palliative Medicine |
| 2003 | American Academy of Hospice and Palliative Care Medicine |
| 1994 | American Board of Psychiatry and Neurology, Subspeciality in Geriatric Psychiatry |
| 1992 | American Board of Psychiatry and Neurology, Psychiatry |
| 1986 | Texas Medical Board |
Experience & Service
Faculty Academic Appointments
Clinical Professor, Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, 2006 - 2019
Associate Professor, Department of Psychiatry, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2007
Associate Professor, Department of Neuro-Oncology, Section of Psychiatry, The University of Texas MD Anderson Cancer Center, Houston, TX, 1997 - 2006
Clinical Assistant Professor, Department of Psychiatry and Behavioral Sciences, The University of Texas Medical School, Houston, TX, 1990 - 2008
Assistant Professor, Department of Neuro-Oncology, Section of Psychiatry, The University of Texas MD Anderson Cancer Center, Houston, TX, 1990 - 1997
Administrative Appointments/Responsibilities
Department Chair, Department of Psychiatry, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - Present
Department Chair ad interim, Department of Psychiatry, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2011
Assistant Clinical Ethicist, Department of Clinical Ethics, The University of Texas MD Anderson Cancer Center, Houston, TX, 1995 - Present
Deputy Chief, Department of Neuro-Oncology, Section of Psychiatry, The University of Texas MD Anderson Cancer Center, Houston, TX, 1994 - 2006
Acting Chief, Department of Neuro-Oncology, Section of Psychiatry, The University of Texas MD Anderson Cancer Center, Houston, TX, 1992 - 1994
Intramural Institutional Committee Activities
Member, Credentials Committee of the Medical Staff, UT MD Anderson Cancer Center, 2024 - Present
Extramural Institutional Committee Activities
Co-Chair, Suicide Risk Steering Committee, The University of Texas MD Anderson Cancer Center, 2018
Member, Pain Task Force, The University of Texas MD Anderson Cancer Center, 2018 - Present
Member, Suicide Risk / Emergency Detainment Order Policy Workgroup, The University of Texas MD Anderson Cancer Center, 2017 - 2018
Member, Professionalism Program Committee, The University of Texas MD Anderson Cancer Center, 2017 - Present
Member, Medical Practice Subcommittee, The University of Texas MD Anderson Cancer Center, 2005 - 2008
Member, Psychosocial Council, The University of Texas MD Anderson Cancer Center, 2005 - Present
Chairman, Clinical Ethics Committee, The University of Texas MD Anderson Cancer Center, 1998 - 1999
Member, Faculty Senate, The University of Texas MD Anderson Cancer Center, 1994 - 2000
Member, Clinical Ethics Committee, The University of Texas MD Anderson Cancer Center, 1993 - 1998
Member, Quality Improvement Committee, The University of Texas MD Anderson Cancer Center, 1993 - 1994
Member, Psychiatry Section Chief Search Committee, The University of Texas MD Anderson Cancer Center, 1992 - 1993
Member, Patient Protection Committee, The University of Texas MD Anderson Cancer Center, 1991 - 1998
Member, Commitment Policy Committee, The University of Texas MD Anderson Cancer Center, 1991 - 1998
Honors & Awards
| 2024 | The Dr. Anastacio De Queiroz Sousa Spirituality in Healthcare Award, Prayers Of The People |
| 2020 | 2020 Excellence in Leadership Award, The University of Texas MD Anderson Cancer Center |
| 2018 | Outstanding Faculty Educator, UTHealth McGovern Medical School Department of Psychiatry and Behavioral Sciences |
| 2015 | Top Cancer Doctors, Newsweek Health |
| 2012 | Top Psychiatrists, US News |
| 2012 | Fellow, American Psycho-Oncology Society |
| 2010 - 2024 | America's Top Psychiatrists, Consumers Research Council of America |
| 2009 - 2024 | Best Doctors in America, Best Doctors |
| 2009 | 7th Holland Distinguished Leadership Award, American Psychosocial Oncology Society |
| 2005 - 2024 | America's Top Doctors for Cancer, Castle Connolly Medical, Ltd |
| 1991 | Dean's Teaching Excellence Award, The University of Texas Medical School Houston |
| 1984 | Honors Evaluation Psychiatry Clerkship, The University of Texas Medical School Houston |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2022. Mental Health Issues Associated With Cancer and Cancer Treatment. Conference. Mental Health Issues Associated With Cancer and Cancer Treatment. Houston, TX, US.
- 2019. Suicide in Cancer Patients. Conference. Suicide in Cancer Patients. Houston, TX, US.
- 2019. Suicide in Cancer Patients and Potential Ethical Dilemmas. Conference. Suicide in Cancer Patients and Potential Ethical Dilemmas. Houston, TX, US.
- 2018. Suicide in Cancer Patients. Conference. Suicide in Cancer Patients. Houston, TX, US.
- 2018. Suicide in Cancer Patients. Conference. Suicide in Cancer Patients. Houston, TX, US.
- 2017. Control is an Illusion and Certainty is a Myth: a Conversation with a Cancer Psychiatrist. Invited. Control is an Illusion and Certainty is a Myth: a Conversation with a Cancer Psychiatrist. Houston, TX, US.
- 2014. Current Topics in the Behavioral Care of Cancer Patients and Cancer Survivors. Conference. Current Topics in the Behavioral Care of Cancer Patients and Cancer Survivors. Houston, TX, US.
- 2012. Who Consents and to Whom Do We Disclose?. Conference. Who Consents and to Whom Do We Disclose?. Houston, TX, US.
- 2010. What Psychiatrists Should Know About Cancer. Conference. What Psychiatrists Should Know About Cancer. Houston, TX, US.
- 2009. Coping with Fear of Cancer Recurrence and Progression. Conference. Coping with Fear of Cancer Recurrence and Progression. Houston, TX, US.
- 2003. Better Living Through Chemistry. Conference. Better Living Through Chemistry. Houston, TX, US.
- 2003. Decision Making: When Decision Makers Disagree. Conference. Decision Making: When Decision Makers Disagree. Houston, TX, US.
- 2003. Depression Post Laryngectomy. Invited. Depression Post Laryngectomy. Houston, TX, US.
- 2003. Depression. Invited. Depression. Houston, TX, US.
- 2002. Psychiatric Distress of Prostate Cancer. Conference. Psychiatric Distress of Prostate Cancer. Houston, TX, US.
- 2002. Depression in Cancer Patients. Conference. Depression in Cancer Patients. Houston, TX, US.
- 2001. Symptom Management: Medications to Help Reduce the Problems and Effects Associated with Brain Tumors. Conference. Symptom Management: Medications to Help Reduce the Problems and Effects Associated with Brain Tumors. Houston, TX, US.
- 2001. Delirium and Alcohol Withdrawal in Cancer Patients. Conference. Delirium and Alcohol Withdrawal in Cancer Patients. Houston, TX, US.
- 2001. Bereavement. Conference. Bereavement. Houston, TX, US.
- 2001. Fatigue: Components of Disability Determination. Conference. Fatigue: Components of Disability Determination. Houston, TX, US.
- 2001. Psychiatric Care of the Cancer Patient. Conference. Psychiatric Care of the Cancer Patient. Houston, TX, US.
- 2001. Delirum and Alcohol Withdrawal in Cancer Patients. Conference. Delirum and Alcohol Withdrawal in Cancer Patients. Houston, TX, US.
- 2000. Coping with the Fear of Recurrence. Conference. Coping with the Fear of Recurrence. Houston, TX, US.
- 2000. Antidepressant Therapy. Conference. Antidepressant Therapy. Houston, TX, US.
- 2000. Neurocognitive and Mood Disturbance as Causes and Symptoms of Fatigue. Conference. Neurocognitive and Mood Disturbance as Causes and Symptoms of Fatigue. Houston, TX, US.
- 2000. Management of Behavioral Side Effects of Interferon-Alpha Therapy. Conference. Management of Behavioral Side Effects of Interferon-Alpha Therapy. Houston, TX, US.
- 1999. Depression and Anger in Cancer. Conference. Depression and Anger in Cancer. Houston, TX, US.
- 1998. Psychiatric Problems in Oncology and Radiation Therapy. Conference. Psychiatric Problems in Oncology and Radiation Therapy. Houston, TX, US.
- 1997. Competency and Surrogate Decision Making. Conference. Competency and Surrogate Decision Making. Houston, TX, US.
- 1997. Update on Psycho-Oncology. Conference. Update on Psycho-Oncology. Houston, TX, US.
- 1997. Neuropsychiatric Syndromes in Neuro-Oncology. Conference. Neuropsychiatric Syndromes in Neuro-Oncology. Houston, TX, US.
- 1996. Cancer and Depression. Conference. Cancer and Depression. Houston, TX, US.
- 1996. The Psychiatric Aspects of Cancer. Invited. The Psychiatric Aspects of Cancer. Houston, TX, US.
- 1995. Diagnosis and Treatment of Psychiatric Disorders in the Cancer Patient. Conference. Diagnosis and Treatment of Psychiatric Disorders in the Cancer Patient. Houston, TX, US.
- 1995. Management of Alcohol Withdrawal in the ICU. Conference. Management of Alcohol Withdrawal in the ICU. Houston, TX, US.
- 1995. Therapeutic Strategies for Immunotherapy-Related Neurotoxicity. Conference. Therapeutic Strategies for Immunotherapy-Related Neurotoxicity. Houston, TX, US.
- 1994. Management of Post-Operative Delirium. Conference. Management of Post-Operative Delirium. Houston, TX, US.
- 1994. Management of Suicidal and Difficult Callers. Conference. Management of Suicidal and Difficult Callers. Houston, TX, US.
- 1994. Consultation-Liaison Psychiatry in Oncology. Conference. Consultation-Liaison Psychiatry in Oncology. Houston, TX, US.
- 1994. Cancer and Depression. Conference. Cancer and Depression. Houston, TX, US.
- 1994. Depression and the Cancer Patient. Conference. Depression and the Cancer Patient. Houston, TX, US.
- 1993. Coping with Cancer and Depression. Conference. Coping with Cancer and Depression. Houston, TX, US.
- 1989. Psychiatric Aspects of Anabolic Steroid Abuse. Conference. Psychiatric Aspects of Anabolic Steroid Abuse. Houston, TX, US.
Regional Presentations
- 2025. Managing and Restoring Mental Health: Ovarcoming Ovarian Cancer. Invited. Zeal for Teal Ovarcome 2025. Houston, Texas, US.
- 2019. Depression and Ovarian Cancer. Conference. Depression and Ovarian Cancer, US.
- 2017. Current Topics in the Behavioral Care of Cancer Patients and Cancer Survivors. Conference. Current Topics in the Behavioral Care of Cancer Patients and Cancer Survivors. Oklahoma City, OK, US.
National Presentations
- 2023. A Population-Based Analysis of the Management of Symptoms of Depression Among Patients with Stage IV Non-Small Cell Lung Cancer in Ontario, Canada, Abstract Plenary Discussant. Conference. Multidisciplinary Thoracic Cancers Symposium. New Orleans, LA, US.
- 2019. Depression, Suicide, and Neglect in Oncologic Emergency Medicine. Conference. 2019 Oncologic Emergency Medicine Conference. Houston, TX, US.
- 2009. Supportive Care Services and the Oncology EMR: Clinic Station at the MD Anderson Cancer Center. Conference. 6th Annual American Psychosocial Oncology Society Conference. Charlotte, NC, US.
- 2008. Controversies About Pharmacologic Interactions Between Tamoxifen and Antidepressant Medications: Implications for Women with Hormone-Sensitive Breast Cancer. Conference. Academy of Psychosomatic Medicine 55th Annual Meeting. Miami, FL, US.
- 2008. Antidepressant Effects on Tamoxifen Metabolism & Efficacy: A Literature Review. Conference. 5th Annual American Psychosocial Oncology Society Conference. Irvine, CA, US.
- 2005. Psycho-Social Issues: Cancer Patient & Family. Conference. 8th Annual Moll Pavilion Cancer Symposium. Cleveland, OH, US.
- 2005. Challenges and Opportunities in Psychosocial Oncology. Conference. 2nd Annual American Psychosocial Oncology Society Conference. Phoenix, AZ, US.
- 2005. Challenges and Opportunities in Psychosocial Oncology. Conference. The Wellness Community of Central Arizona Panel Discussion. Phoenix, AZ, US.
- 2004. Psychosocial Needs of Women with Breast Cancer. Conference. American Cancer Society: Breast Cancer Survivorship. Houston, TX, US.
- 2003. Depression in the Cancer Patient. Conference. 6th Annual Meeting Association of Physician Assistants in Oncology. Austin, TX, US.
- 2001. Assessment and Novel Management Strategies for Chemotherapy-Induced Neuropsychiatric Syndromes: Biological Response Modifiers as a Model. Conference. American Society for Psychosocial, Behavioral Oncology, AIDS Annual Meeting. San Antonio, TX, US.
- 2000. Immunotherapy of Cancer Patients: Neurobehavioral Consequences. Conference. PsychoNeuroImmunology Research Society Annual Meeting. Cape Fear, NC, US.
- 1999. Interferon Toxicity: Neuropsychiatric Aspects. Conference. The Cleveland Clinic Cancer Center Experimental Therapeutics Conference. Cleveland, OH, US.
- 1997. Psychostimulant Treatment of Neurobehavioral Slowing and Functional Impairment in Patients with Primary Brain Tumors. Conference. Society for Neuro-Oncology Annual Meeting. Charlottesville, VA, US.
- 1997. Psychiatry of Brain Tumors. Conference. National Brain Tumor Foundation Conference. Houston, TX, US.
- 1996. Psychopharmacological and Prescribing Issues in Patients with Primary Brain Tumors. Conference. World Congress of Psycho-Oncology. New York, NY, US.
- 1996. The Psychiatric Effects of Interferon: Theories and Therapeutic Approaches. Conference. Integrated Therapeutics Group, Inc. Short Hills, NJ, US.
- 1996. Possible Pharmacologic Interventions for Central Nervous System Side Effects of Alfa Interferon. Conference. Side Effects of Alfa Interferon: Possible Clinical Causes and Intervention Strategies. Baltimore, MD, US.
International Presentations
- 2011. Psychostimulants in the Management of Brain Tumors. Conference. American Society of Clinical Oncology Annual Meeting. Chicago, US.
- 2010. Depression and Anxiety. Conference. Aplastic Anemia & Myelodysplastic Syndrome International Foundation. Houston, US.
- 2004. Update on Activities of the American Psychosocial Oncology Society. Conference. 7th World Congress of Psycho-Oncology. Copenhagen, DK.
- 1998. Psychiatric Side Effects of the Interferons. Conference. 2nd United States Rebetol Investigators Meeting. Fajardo, PR.
Grant & Contract Support
| Date: | 2009 - 2014 |
| Title: | Adherence to Swallowing Rehabilitation Exercises in Head & Neck Cancer |
| Funding Source: | National Institute of Dental & Craniofacial Research |
| Role: | Significant Contributor |
| ID: | 1R01 DE019141-0 |
| Date: | 2008 - 2010 |
| Title: | Efficacy of Cancer Support Programs: A Social Comparison Theory Analysis |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | 1R21CA126854 |
| Date: | 2005 - 2010 |
| Title: | Group Composition and Efficacy of Cancer Support Groups |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | CA109143-01 |
| Date: | 2004 - 2008 |
| Title: | Depression and Adherence in Head and Neck Cancer |
| Funding Source: | National Cancer Institute |
| Role: | Co-I |
| ID: | RO3 CA108358-01 |
| Date: | 2003 - 2008 |
| Title: | Depression Screening and Treatment in Ovarian Cancer Patients on Active Treatment |
| Funding Source: | National Cancer Institute |
| Role: | Co-I |
| ID: | 1KO7 CA093512 01A2 |
| Date: | 2003 - 2007 |
| Title: | A Pilot In-Home Intervention for Depression in Ovarian Cancer Patients |
| Funding Source: | Lance Armstrong Foundation |
| Role: | Co-I |
| ID: | 1 CF2002-0000832 HM 01 |
| Date: | 1997 - 2001 |
| Title: | A Quantitative Assessment of Depression and Cognitive Impairment Secondary to Alpha Interferon Treatment |
| Funding Source: | Integrated Therapeutics Group, Inc |
| Role: | PI |
| ID: | unknown |
| Date: | 1991 - 1993 |
| Title: | The Biochemical, Physiologic and Behavioral Effects of Biological Response Modifiers |
| Funding Source: | Physicians' Referral Service, MDACC |
| Role: | Co-I |
| ID: | unknown |
| Date: | 1991 - 1993 |
| Title: | Brain Electrical Activity Mapping During Intoxication with Delta-9-Tetrahydrocannabinol (THC) |
| Funding Source: | National Institute on Drug Abuse |
| Role: | Co-I |
| ID: | unknown |
Selected Publications
Peer-Reviewed Articles
- Tsimberidou, AM, Skliris, A, Valentine, AD, Shaw, JV, Hering, U, Vo, H, Chan, TO, Armen, RS, Cottrell, JR, Pan, JQ, Tsichlis, PN. AKT inhibition in the central nervous system induces signaling defects resulting in psychiatric symptomatology. Cell and Bioscience 12(1), 2022. e-Pub 2022. PMID: 35525984.
- Valentine AD, Brown JB, Lacourt T, Chen M, Garza Rnd DL, Bruera E. Frequency of anxiety and depression and screening performance of the Edmonton Symptom Assessment Scale in a psycho-oncology clinic. Psycho-Oncology 31(2):290-297, 2021. e-Pub 2021. PMID: 34546618.
- Gawad NA, Kohner A, Ali T, Hofstetter W, Valentine A. Valproic acid attenuates postoperative psychosis following aggressive resection of a intracardiac carcinoid neuroendocrine tumor: a case report. Psychosomatics 59(6):607-611, 2018. e-Pub 2018. PMID: 29703550.
- Elsayem AF, Bruera E, Valentine A, Warneke CL, Wood GL, Yeung SJ, Page VD, Silvestre J, Brock PA, Todd KH. Advance directives, hospitalization, and survival among advanced cancer patients with delirium presenting to the emergency department, a prospective study. Oncologist 22(11):1368-1373, 2017. e-Pub 2017. PMID: 28765503.
- Shinn EH, Valentine A, Baum G, Carmack C, Kilgore K, Bodurka D, Basen-Engquist K. Comparison of four brief depression screening instruments in ovarian cancer patients: diagnostic accuracy using traditional versus alternative cutpoints. Gynecol Oncol 145(3):562-568, 2017. e-Pub 2017. PMID: 28400146.
- Elsayem AF, Wood GL, Valentine AD. Reply to patients with delirium and advanced solid cancer in the emergency department: A challenge for the emergency practitioner, oncologist, and intensivist; and delirium in patients with advanced cancer: Screening to cure or caring to prevent?. Cancer 123(4):706-707, 2017. e-Pub 2017. PMID: 27861756.
- Elsayem AF, Bruera E, Valentine AD, Warneke CL, Yeung SC, Page VD, Wood GL, Silvestre J, Holmes HM, Brock PA, Todd KH. Delirium frequency among advanced cancer patients presenting to an emergency department: a prospective, randomized, observational study. Cancer 122(18):2918-2924, 2016. e-Pub 2016. PMID: 27455035.
- Shinn EH, Valentine A, Jethanandani A, Basen-Engquist K, Fellman B, Urbauer D, Atkinson E, Yusuf SW, Lenihan D, Woods ML, Kies MS, Sood AK, Carmack C, Morrison WH, Gillenwater A, Sturgis EM, Garden AS. Depression and oropharynx cancer outcome. Psychosom Med 78(1):38-48, 2016. e-Pub 2016. PMID: 26632757.
- Shinn EH, Lenihan DJ, Urbauer DL, Basen-Engquist KM, Valentine A, Palmero L, Woods ML, Patel P, Nick AM, Shahzad MM, Stone RL, Golden A, Atkinson E, Lutgendorf SK, Sood AK. Impact of cardiovascular comorbidity on ovarian cancer mortality. Cancer Epidemiol Biomarkers Prev 22(11):2102-2109, 2013. e-Pub 2013. PMID: 24045927.
- Petzel MQ, Parker NH, Valentine AD, Simard S, Nogueras-Gonzalez GM, Lee JE, Pisters PW, Vauthey JN, Fleming JB, Katz MH. Fear of cancer recurrence following curative pancreatectomy: a cross-sectional study in survivors of pancreatic and periampullary tumors. Ann Surg Oncol 19(13):4078-4084, 2012. e-Pub 2012. PMID: 22875648.
- Stouter DK, Wallace A, Duffy J, Rashid A, Valentine A. Long coats, short coats and no coats: chaplaincy presents to psychiatry at the University of Texas MD Anderson Cancer Center, a report. J Pastoral Care Counsel 66(1):6, 2012. e-Pub 2012. PMID: 23045758.
- Shinn EH, Taylor CL, Kilgore K, Valentine A, Bodurka DC, Kavanagh J, Sood A, Li Y, Basen-Engquist K. Associations with worry about dying and hopelessness in ambulatory ovarian cancer patients. Palliat Support Care 7(7):299-306, 2009. e-Pub 2009. PMID: 19788771.
- Doherty DB, Mittendorf EA, Valentine AD, Perrier ND. An elderly woman with primary hyperparathyroidism exhibits improvement of neurocognitive dysfunction after parathyroidectomy. J Am Geriatr Soc 55(10):1689-1691, 2007. e-Pub 2007. PMID: 17908077.
- Holland JC, Andersen B, Breitbart WS, Dabrowski M, Dudley MM, Fleishman S, Foley GV, Fulcher C, Greenberg DB, Greiner CB, Handzo RG, Jacobsen PB, Knight SJ, Learson K, Levy MH, Manne S, McAllister-Black R, Peterman A, Riba MB, Slatkin NE, Valentine A, Zevon MA. Distress management. J Natl Compr Canc Netw 5:66-98, 2007. e-Pub 2007. PMID: 17239328.
- Scheibel RS, Valentine AD, O'Brien S, Meyers CA. Cognitive dysfunction and depression during treatment with interferon-alpha and chemotherapy. J Neuropsychiatry Clin Neurosci 16(2):185-191, 2004. e-Pub 2004. PMID: 15260370.
- Hauser P, Khosla J, Aurora H, Laurin J, Kling MA, Hill J, Gulati M, Thornton AJ, Schultz RL, Valentine AD, Meyers CA, Howell CD. A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C. Mol Psychiatry 7(9):942-947, 2002. e-Pub 2002. PMID: 12399946.
- Hauser P, Soler R, Reed S, Kane R, Gulati M, Khosla J, Kling MA, Valentine AD, Meyers CA. Prophylactic treatment of depression induced by interferon-alpha. Psychosomatics 41(5):439-441, 2000. e-Pub 2000. PMID: 11015632.
- Valentine AD. Managing the neuropsychiatric adverse effects of interferon treatment. BioDrugs 11(4):229-237, 1999. e-Pub 1999.
- Meyers CA, Weitzner MA, Valentine AD, Levin VA. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol 16(7):2522-2527, 1998. e-Pub 1998. PMID: 9667273.
- Strite D, Valentine AD, Meyers CA. Manic episodes in two patients treated with interferon alpha. J Neuropsychiatry Clin Neurosci 9(2):273-276, 1997. e-Pub 1997. PMID: 9144108.
- Olofsson SM, Weitzner MA, Valentine AD, Baile WF, Meyers CA. A retrospective study of the psychiatric management and outcome of delirium in the cancer patient. Support Care Cancer 4(5):351-357, 1996. e-Pub 1996. PMID: 8883228.
- Weitzner MA, Meyers CA, Valentine AD. Methylphenidate in the treatment of neurobehavioral slowing associated with cancer and cancer treatment. J Neuropsychiatry Clin Neurosci 7(3):347-350, 1995. e-Pub 1995. PMID: 7580196.
- Volkow ND, Tancredi LR, Grant C, Gillespie H, Valentine A, Mullani N, Wang GJ, Hollister L. Brain glucose metabolism in violent psychiatric patients: a preliminary study. Psychiatry Res 61(4):243-253, 1995. e-Pub 1995. PMID: 8748468.
- Meyers CA Valentine AD. Neurological and psychiatric adverse effects of immunological therapy. CNS Drugs 3(1):56-68, 1995. e-Pub 1995.
- Dobbs FR, Banks W, Fleishaker JC, Valentine AD, Kinsey BM, Franceschini MP, Digenis GA, Tewson TJ. Studies with [11C]alprazolam: an agonist for the benzodiazepine receptor. Nucl Med Biol 22(4):459-466, 1995. e-Pub 1995. PMID: 7550022.
- Pavol MA, Meyers CA, Rexer JL, Valentine AD, Mattis PJ, Talpaz M. Pattern of neurobehavioral deficits associated with interferon alpha therapy for leukemia. Neurology 45(5):947-950, 1995. e-Pub 1995. PMID: 7746412.
- Valentine AD, Meyers CA, Talpaz M. Treatment of neurotoxic side effects of interferon-alpha with naltrexone. Cancer Invest 13(6):561-566, 1995. e-Pub 1995. PMID: 7583704.
- Meyers CA, Weitzner M, Byrne K, Valentine A, Champlin RE, Przepiorka D. Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation. J Clin Oncol 12(4):820-826, 1994. e-Pub 1994. PMID: 8151324.
- Meyers CA, Valentine AD, Wong FC, Leeds NE. Reversible neurotoxicity of interleukin-2 and tumor necrosis factor: correlation of SPECT with neuropsychological testing. J Neuropsychiatry Clin Neurosci 6(3):285-288, 1994. e-Pub 1994. PMID: 7950353.
- Volkow ND, Valentine A, Kulkarni M. Radiological and neurological changes in the drug abuse patient: a study with MRI. J Neuroradiol 15(3):288-293, 1988. e-Pub 1988. PMID: 3266757.
- Volkow ND, Warner N, McIntyre R, Valentine A, Kulkarni M, Mullani N, Gould L. Cerebral involvement in systemic lupus erythematosus. Am J Physiol Imaging 3(2):91-98, 1988. e-Pub 1988. PMID: 3260788.
- Tsimberidou A, Skliris A, Valentine A, Shaw J, Hering U, Vo HH, Chan TO, Armen RS, Cottrell JR, Pan JQ, Tsichlis PN. AKT Inhibition in the Central Nervous System Induces Signaling Defects Resulting in Psychiatric Symptomatology. Cell & Bioscience.
Invited Articles
- Kurkijian N, Tucker P, Ostermeyer B, Valentine AD. Chemotherapy, immunotherapy, and psychotropic use in cancer patients: a review of psychiatric side effects. Psychiatr Ann 47(4):200-208, 2017. e-Pub 2017.
- Valentine AD, Meyers CA. Neurobehavioral effects of interferon therapy. Curr Psychiatry Rep 7(4):391-395, 2005. e-Pub 2005.
- Valentine AD. Cancer pain and depression: management of the dual-diagnosed patient. Curr Pain Headache Rep 7:262-269, 2003. e-Pub 2003. PMID: 12828875.
Review Articles
- Valentine AD, Meyers CA. Cognitive and mood disturbance as causes and symptoms of fatigue in cancer patients. Cancer 92(6 Suppl):1694-1698, 2001. e-Pub 2001. PMID: 11598889.
- Valentine AD, Meyers CA, Kling MA, Richelson E, Hauser P. Mood and cognitive side effects of interferon-alpha therapy. Semin Oncol 25(1 Suppl 1):39-47, 1998. e-Pub 1998. PMID: 9482539.
Professional Educational Materials
- Guiliano R, Agarwala SS, Hayes JM, Rubin KR, Valentine AD. Exemplars in Melanoma Nursing in Melanoma Care Options: Oncology Nursing Update. PharmAdura, LLC, 2007.
- . Net Medical Ethics, Internet Continuing Medical Education. The University of Texas MD Anderson Cancer Center, 2007.
- Moon S Valentine AD. Mood Disorder in a Lung Cancer Patient, teaching aid for the internet version Cancer in the Nervous System, 2nd Edition, 2002.
- . Net Medical Ethics, Internet Continuing Medical Education. The University of Texas MD Anderson Cancer Center, 2002.
- . Net Medical Ethics, Internet Continuing Medical Education. The University of Texas MD Anderson Cancer Center, 2000.
Other Articles
- Valentine AD Association of Timing of Psychiatry Consultation and Length of Stay and Length of Stay Index in Hospitalized Patients with Cancer: Risk-Adjusted Outcomes. The Joint Commission Journal on Quality and Patient Safety, 2026.
- Valentine AD How to live with the fear of recurrence. Coping:54-55, 1998.
- Valentine AD Psychological and rheumatic symptoms of women requesting silicon breast implant removal (guest editorial review). Breast Diseases: A Yearbook Quarterly 7:99-100, 1996.
- Valentine AD Balancing our lives: a study of the married couples experience with breast cancer recurrence (guest editorial review). Breast Diseases: A Yearbook Quarterly 7:101-102, 1996.
- Valentine AD Monitoring versus blunting styles of coping with cancer influence the information patients want and need about their disease (guest editorial review). Breast Diseases: A Yearbook Quarterly 7:100-101, 1996.
- Maria Shabih, Adelita D. Martinez, Valentine AD, Deepti A. Chopra Interactive Clinical Dashboar e Clinical Dashboard for Psy d for Psychiatric Oncology Ser chiatric Oncology Services at a Cancer vices at a Cancer Institution: A Quality Initiative. Advances in Cancer Education and Quality Improvement (ACE-QI) 1(2).
Editorials
- Valentine AD. Commentary on: The Transplant Evaluation Rating Scale Predicts Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation. Practice Update, 2020.
- Valentine AD. Commentary on: A longitudinal study of depression, fatigue, and sleep disturbances as a symptom cluster in women with breast cancer [J Pain Symptom Manage, 2015;49:707-715]. Breast Diseases: A Year Book Quarterly 26:203-204, 2015.
Abstracts
- Carmack CL, Cohen L, Ann-Yi S, Valentine AD, Fossella F, Bruera E. Changing the culture for psychosocial care: does it need changing?. Proceedings of the Palliative Care in Oncology Symposium, 2016. e-Pub 2016.
- Carmack CL, Cohen L, Parker P, Lambert D, Ann-Yi S, Valentine AD, Fossella F, Bruera E. Changing the culture for psychosocial care- does it need changing?. Proceedings of the Annual Meeting of the American Society of Clinical Oncology, 2016. e-Pub 2016.
- Rashid A, Makanjuola TB, Saryakar S, Valentine AD, De La Garza II R. Sleep disturbances predict higher levels of depression, anxiety and fatigue in cancer patients. Psychooncology 25(S2):51-52, 2016. e-Pub 2016.
- De La Garza II R, Ignatius J, Gonzalez R, Lynn R, Rashid A, Tan D, Bell M, Valentine A. The importance of race and ethnicity in depression, anxiety and distress in cancer patients. Psychooncology 25(S2):53-54, 2016. e-Pub 2016.
- Elsayem AF, Valentine AD, Warneke CL, Page VD, Bruera E, Yeung SJ, Brock PA, Silvestre J, Holmes HM, Todd KH. Delirium assessment in advanced cancer patients presenting to the emergency department of a comprehensive cancer center. Proceedings of the 2015 Palliative Care in Oncology Symposium, 2015. e-Pub 2015.
- Hughes MK, De La Garza II R, Valentine AD. Sexuality: an important quality of life issue. Proceedings of the Fourth Annual Palliative Care Conference- Palliative Care Across the Lifespan, 2015. e-Pub 2015.
- De La Garza II R, Thekdi S, Rashid A, Lynn R, Ignatius J, Gonzalez R, Tan D, Rickman K, Hughes M, Joseph N, Onyemeh Sea A, Smith C, Bell M, Valentine A. Characterization of demographics and psychiatric symptoms in 500 patients enrolled in the MD Anderson Cancer Center psychiatry patient registry protocol. Psychooncology 24(S2):163, 2015. e-Pub 2015.
- Rashid A, De La Garza II R, Joseph N, Onyemeh Sea A, Valentine A. Correlations of high symptoms assessment scale scores to demographic and other variables. Psychooncology 24(S2):168-169, 2015. e-Pub 2015.
- Ignatius J, Bell M, Rashid A, Thekdi S, De La Garza II R, Nichols D, Valentine A. PsychCare database: development and implementation. Psychooncology 24(S2):172, 2015. e-Pub 2015.
- Lynn R, De La Garza II R, Joseph N, Onyemeh Sea A, Valentine A. Use of the NCCN distress thermometer and emotional problem list in predicting psychiatric symptoms. Psychooncology 24(S2):75, 2015. e-Pub 2015.
- Valentine A, Boehnke Michaud L. Antidepressant effects on tamoxifen metabolism and efficacy: a literature review. Psychooncology 17(S1):S89, 2008. e-Pub 2008.
- Shinn EH, Kilgore KK, Valentine A, Carmack Taylor C, Sood A, Li Y, Bodurka D, Kavanagh J, Basen-Engquist K. Unexpected associations with worry about dying and hopelessness in ambulatory ovarian cancer patients. Psychooncology 16(S2):S256-S257, 2007. e-Pub 2007.
- Rashid A, Valentine AD. Psychiatric consultations for cancer patients evacuated from Hurricane Katrina. Psychooncology 16(S1):S99-S100, 2007. e-Pub 2007.
- Shinn E, Basen-Engquist K, Taylor C, Valentine A. Depression and adherence in head and neck cancer. National Cancer Institute and Lance Armstrong Foundation Small Grants Grantee Meeting, 2005. e-Pub 2005.
- Shinn E, Basen-Engquist K, Taylor CC, Valentine A. An in-home pilot intervention for depression in depressed ovarian cancer patients. National Cancer Institute and Lance Armstrong Foundation Small Grants Grantee Meeting, 2005. e-Pub 2005.
- Hughes MK, Valentine AD. Multidisciplinary model for providing psychiatric care in an oncology setting. Psychooncology 13(S1):S27-S28, 2004. e-Pub 2004.
- Pentz R, Valentine AD, Brody B, Youngner S. How I see this case: a possible suicide. Proceedings of the Third Annual American Society for Bioethics and Humanities Meeting, 2000. e-Pub 2000.
- Pentz R, Valentine AD, Flamm A, Volker D. Ethics consultation: sharpening skills on actual cases. Proceedings of the Third Annual American Society for Bioethics and Humanities Meeting, 2000. e-Pub 2000.
- Meyers CA, Valentine AD, Levin VA. Methylphenidate to improve neurobehavioral slowing and functional independence in brain tumor patients. Proceedings of the Society for Neuro-Oncology Second Annual Scientific Meeting, 1997. e-Pub 1997.
Book Chapters
- Valentine AD. Central Nervous System Tumors. In: Psycho-Oncology, 2020.
- Valentine AD. Central nervous system tumors. In: Psycho-Oncology. 3rd. Oxford University Press, 87-91, 2015.
- Valentine, AD. Psychiatric emergencies and disorders: anxiety disorders. In: Quick Reference for Oncology Clinicians: The Psychiatric and Psychological Dimensions of Cancer Symptom Management. 2nd. American Psychosocial Oncology Society/International Psycho-Oncology Society Press, 45-53, 2015.
- Valentine, AD. Psychiatric emergencies and disorders: cognitive disorders. In: Quick Reference for Oncology Clinicians: The Psychiatric and Psychological Dimensions of Cancer Symptom Management. 2nd. American Psychosocial Oncology Society/International Psycho-Oncology Society Press, 63-73, 2015.
- Valentine AD. Psychiatric emergencies and disorders: mood disorders. In: Quick Reference for Oncology Clinicians: The Psychiatric and Psychological Dimensions of Cancer Symptom Management. 2nd. American Psychosocial Oncology Society/International Psycho-Oncology Society Press, 53-63, 2015.
- Valentine AD. Issues specific to common cancer sites: brain cancer. In: Quick Reference for Oncology Clinicians: The Psychiatric and Psychological Dimensions of Cancer Symptom Management. 2nd. American Psychosocial Oncology Society/International Psycho-Oncology Society Press, 141-149, 2015.
- Lynn R, Valentine AD. Psychiatric emergencies. In: Psychopharmacology in Oncology and Palliative Care. Springer, 317-330, 2014.
- Ngo A, Valentine A. Mental health: behavioral disorders. In: Cancer: Rehabilitation Medicine Quick Reference. Demos Medical Publishing, 93-94, 2013.
- Valentine AD. Mood disorders. In: The MD Anderson Manual of Psychosocial Oncology. McGraw-Hill, 59-69, 2010.
- Duffy JD, Valentine AD. Delirium. In: The MD Anderson Manual of Psychosocial Oncology. McGraw-Hill, 87-97, 2010.
- Valentine AD, Bruera E. Symptomatic therapies. In: Cognition and Cancer. Cambridge University Press, 258 - 269, 2008.
- Braun I, Valentine A. Depression, anxiety, and delirium. In: Cancer Management: A Multidisciplinary Approach. 11th. CMPMedica, 923-933, 2008.
- Valentine AD. Depression, anxiety and delirium. In: Cancer management: A Multidisciplinary Approach. 10th. The Oncology Group, 855-899, 2007.
- Valentine AD. Issues specific to the cancer site brain. In: Quick Reference for Oncology Clinicians: The Psychiatric and Psychological Dimensions of Cancer Symptom Management. American Psychosocial Oncology Society/International Psycho-Oncology Society Press, 107-112, 2006.
- Valentine AD. Common psychiatric disorders: mood disorders. In: Quick Reference for Oncology Clinicians: The Psychiatric and Psychological Dimensions of Cancer Symptom Management. American Psychosocial Oncology Society/International Psycho-Oncology Society Press, 44-51, 2006.
- Valentine AD. Common psychiatric disorders: anxiety disorders. In: Quick Reference for Oncology Clinicians: The Psychiatric and Psychological Dimensions of Cancer Symptom Management. American Psychosocial Oncology Society/International Psycho-Oncology Society Press, 39-44, 2006.
- Valentine AD. Common psychiatric disorders: cognitive disorders. In: Quick Reference for Oncology Clinicians: The Psychiatric and Psychological Dimensions of Cancer Symptom Management. American Psychosocial Oncology Society/International Psycho-Oncology Society Press, 51-57, 2006.
- Valentine AD. Depression, anxiety and delirium. In: Cancer Management: A Multidisciplinary Approach. 9th. The Oncology Group, 887-901, 2005.
- Valentine AD, Bickham JG. Delirium and substance withdrawal. In: Acute Care of the Cancer Patient. 1st. Marcel Dekker, 545-557, 2005.
- Valentine AD. Depression, anxiety and delirium. In: Cancer Management: A Multidisciplinary Approach. 8th. The Oncology Group, 869-882, 2004.
- Valentine AD. Depression, anxiety and delirium. In: Cancer Management: A Multidisciplinary Approach. 7th. The Oncology Group, 865-879, 2003.
- Valentine AD, Passik SD, Massie MJ. Psychiatric and psychosocial issues. In: Cancer in the Nervous System. 2nd. Oxford University Press, 572-589, 2002.
- Valentine AD. Depression, anxiety and delirium. In: Cancer Management: A Multidisciplinary Approach. 6th. PRR, Inc, 817-829, 2002.
- Valentine AD. Depression, anxiety and delirium. In: Cancer Management: A Multidisciplinary Approach. 5th. PRR, Inc, 765-778, 2001.
- Valentine AD. Depression, anxiety and delirium. In: Cancer Management: A Multidisciplinary Approach. 4th. PRR, Inc, 775-788, 2000.
- Storey P, Rubenstein E, Valentine AD, Loprinzi C. Symptom management and hospice care. In: Cancer Management: A Multidisciplinary Approach. 3rd. PRR, Inc, 799-832, 1999.
- Knobf MT, Pasacreta F, Valentine AD, McCorkle R. Psychological responses to treatment: chemotherapy, hormonal therapy, and immunotherapy. In: Psycho-oncology. 1st. Oxford University Press, 277-288, 1998.
Books (edited and written)
- Duffy JD, Valentine AD. The MD Anderson Manual of Psychosocial Oncology. McGraw-Hill, 2010.
Letters to the Editor
- Hui D, Valentine A, Bruera E. Neuroleptics for Delirium: More Research is Needed. JAMA Intern Med 177: 1052-1053, 2017.
- Rashid A, Valentine A. Charles Bonnet Syndrome as a manifestation of leptomeningeal metastases. Psychosomatics 51: 447, 2010.
- Mittendorf E, AD V, Perrier N. An Elderly Woman With Primary Hyperparathyroidism Exhibits Improvement of Neurocognitive Dysfunction After Parathyroidectomy. Journal of the American Geriatrics Society 55, 2007.
- Valentine AD, Pavol MA, Meyers CA. Neuropsychological deficits and abnormal electro-encephalogram associated with interferon alpha therapy. Neurology (reply to correspondence). Neurology 47: 308-309, 1996.
- Valentine AD, Meyers CA. Successful treatment of interferon-alpha-induced mood disorder with nortriptyline. Psychosomatics 36: 418-419, 1995.
- Ritchie KS, Rubenstein EB, Valentine AD. Do not resuscitate orders in the emergency department. Am J Med 93: 586-587, 1992.
Patient Reviews
CV information above last modified July 22, 2026